Day Care in Robotic Surgery Hysterectomy. Investigate Quality of Life and Safety With Same Day Discharge After Robotic Hysterectomy for Patients With Benign and Malignant Disease. A Multicenter Randomized Study With 3 Hospitals in Stockholm Sweden.
DARSH - A Multicenter Randomized Controlled Trial: Day-care vs Overnight Stay in Robotic Assisted Hysterectomy in Patients With Bening Disease and Endometrial Cancer.
Karolinska Institutet
300 participants
Jan 1, 2025
INTERVENTIONAL
Conditions
Summary
Patients undergoing robotic assisted hysterectomy in three different hospitals in Stockholm will be randomized to day-care (going home the same day as the surgery) or admission (staying at least one night after surgery). The aim with this study is to investigate if patients in day-care recover as fast/faster as the other group that stays in the hospital. Both patients with benign disease and malign disease (endometrial cancer) will be included in the study. Patients quality of life (QoL) will be measured before surgery and after surgery at day 3,7 and 30 with a questionnaire called Eq-5D-5L from Euroqol. The questionnaire is validated for postoperative QoL and widely used. Complications due to surgery within the 30 first days after surgery will also be recorded in the two groups to make sure it is safe for the patients to go home the same day as their surgery.
Eligibility
Inclusion Criteria3
- Patient that are planned to undergo total robotic hysterectomy with or without adnexal surgery at the three sites.
- Both benign conditions and endometrial cancer.
- All BMI groups and all uterus sizes.
Exclusion Criteria5
- Age not over 75 years old,
- No company at home first night after surgery
- ASA class 3 that is not only because of high BMI.
- Simultaneous prolapse surgery/lymph node evacuation.
- Severe endometriosis or patients with chronic pain conditions that have a special pain regimen after surgery.
Interventions
The patient return to home the same day as the surgery is performed.
The patient spend the night at the hospital and can not go home until the next morning.
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07233811